University of Iowa Hospitals and Clinics, Department of Orthopaedics, Iowa City, Iowa.
J Arthroplasty. 2017 Aug;32(8):2390-2394. doi: 10.1016/j.arth.2017.03.014. Epub 2017 Mar 16.
The United States is in the midst of an opioid epidemic. Little is known about perioperative opioid use for total knee arthroplasty (TKA). The purpose of this study was to identify rates of preoperative opioid use, evaluate postoperative trends and identify risk factors for prolonged use after TKA.
Patients who underwent primary TKA from 2007-2014 were identified within the Humana database. Postoperative opioid use was measured by monthly prescription refill rates. A preoperative opioid user (OU) was defined by history of opioid prescription within 3 months prior to TKA and a non-opioid user (NOU) was defined by no history of prior opioid use. Rates of opioid use were trended monthly for one year postoperatively for all cohorts.
73,959 TKA patients were analyzed and 23,532 patients (31.2%) were OU. OU increased from 30.1% in 2007 to 39.3% in 2014 (P < .001). Preoperative opioid use was the strongest predictor for prolonged opioid use following TKA, with OU filling significantly more opioid prescriptions than NOU at every time point analyzed. Younger age, female sex and other intrinsic factors were found to significantly increase the rate of opioid refilling following TKA throughout the postoperative year.
Approximately one-third of TKA patients use opioids within 3 months prior to surgery and this percentage has increased over 9% during the years included in this study. Preoperative opioid use was most predictive of increased refills of opioids following TKA. However, other intrinsic patient characteristics were also predictive of prolonged opioid use.
美国正处于阿片类药物泛滥的困境之中。对于全膝关节置换术(TKA)围手术期阿片类药物的使用情况知之甚少。本研究的目的是确定术前阿片类药物使用的比率,评估术后趋势,并确定 TKA 后延长使用的风险因素。
在 Humana 数据库中确定了 2007-2014 年间接受初次 TKA 的患者。术后阿片类药物使用情况通过每月处方补充率来衡量。术前阿片类药物使用者(OU)定义为在 TKA 前 3 个月内有阿片类药物处方史,而非阿片类药物使用者(NOU)定义为无既往阿片类药物使用史。对所有队列患者在术后一年内每月进行阿片类药物使用趋势分析。
分析了 73959 例 TKA 患者,其中 23532 例(31.2%)为 OU。OU 从 2007 年的 30.1%增加到 2014 年的 39.3%(P<.001)。术前阿片类药物使用是 TKA 后长期使用阿片类药物的最强预测因素,OU 在每个分析的时间点都比 NOU 开更多的阿片类药物处方。研究发现,年龄较小、女性和其他内在因素显著增加了 TKA 后术后一年内阿片类药物的再配药率。
大约三分之一的 TKA 患者在手术前 3 个月内使用阿片类药物,在本研究包括的年份中,这一比例增加了 9%以上。术前阿片类药物使用是 TKA 后阿片类药物再配药的最主要预测因素。然而,其他内在的患者特征也是延长阿片类药物使用的预测因素。